Ceritinib (Cerinib) 150mg*30's | DIL Bangladesh Generic | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Делиться
Product description

Generic Information: Cerinib (Bangladesh)

Cerinib is a Bangladeshi generic of ceritinib manufactured by Drug International Limited (DIL), one of Bangladesh's leading pharmaceutical exporters. Each capsule contains 150 mg of ceritinib, supplied in a 30-capsule pack. As an affordable generic of the second-generation ALK inhibitor, Cerinib brings ALK-targeted lung-cancer therapy within reach for patients in lower-income markets.

What Is Cerinib Used For?

Cerinib is used for ALK-positive metastatic non-small cell lung cancer, particularly in patients whose disease has progressed on crizotinib. It provides an oral, targeted treatment option for this molecularly defined lung-cancer subtype, and its 30-capsule pack is a convenient size for starting therapy or for monthly reordering at the standard dose.

How Does Ceritinib Work?

Ceritinib blocks anaplastic lymphoma kinase, the driver protein behind ALK-rearranged lung cancer. By inhibiting ALK and related kinases, the drug cuts off the growth signals that sustain cancer cells. Because it is a second-generation inhibitor, it overcomes many of the ALK mutations that cause crizotinib resistance, restoring disease control after first-line therapy fails.

Indications

The indication is ALK-positive metastatic NSCLC confirmed by a validated ALK test. Cerinib is used after crizotinib progression and, where approved, as initial therapy. It is a prescription medicine that must be started and monitored by an oncologist.

Dosage

The recommended dose is 450 mg (three capsules) once daily with food, matching the efficacy of the 750 mg fasting dose with better tolerability. At this dose, a 30-capsule pack lasts 10 days; patients on the 750 mg fasting schedule use five capsules daily, so a pack lasts six days. The physician adjusts dosing based on tolerance and liver-function monitoring.

Side Effects

Common side effects are diarrhoea, nausea, vomiting, abdominal pain, fatigue and reduced appetite. Clinically important effects include liver enzyme elevation, hyperglycaemia, QT prolongation and, rarely, pneumonitis. Patients need regular monitoring of liver function, blood glucose and the ECG, and should report persistent gastrointestinal symptoms or new breathing problems.

Storage

Store Cerinib capsules at room temperature, away from moisture and light, in the original packaging and out of reach of children. Do not use after the expiry date.

Why Choose Cerinib Through GLT?

Cerinib offers ceritinib at an accessible price point for patients who would otherwise struggle to afford originator therapy. GLT sources this Bangladeshi generic through verified channels, supplying genuine DIL product with full documentation, and shipping internationally from a Hong Kong-licensed facility.

How to Order

Contact GLT on WhatsApp at +86 15234153837 or by email at [email protected] to order Cerinib. We will confirm availability, pricing and delivery to your country before you place an order.

FAQ

Is Cerinib the same as Zykadia? Yes, Cerinib is a generic containing the same active ingredient ceritinib, with the same indication and dosing, at a lower cost.

Who manufactures Cerinib? Cerinib is made by Drug International Limited (DIL), a major Bangladeshi pharmaceutical manufacturer.

How long does a 30-capsule pack last? At the standard 450 mg daily dose (three capsules), a pack lasts 10 days.

Related Oncology Products

Mounjaro KwikPen (Тирзепатид) 10–60мг/2,4мл многодозовая ручка | Eli Lilly (США) | GLT

Mounjaro KwikPen — многодозовая ручка Eli Lilly для одного пациента, шесть дозировок для США (10–60мг/2,4мл,...

Орфорглипрон (OriYo) 0,8–17,2 мг таблетки | Бангладешский дженерик пероральный GLP-1 | GLT

Дженерик орфорглипрона от National Drug Co. (Бангладеш), 6-ступенчатая титрация для контроля веса

Baricent (Барицитиниб) 2мг | Дженерик-ингибитор JAK1/JAK2 | Incepta Pharmaceuticals Ltd. | GLT

Дженерик барицитиниба (ингибитора JAK1/JAK2) от Incepta Pharmaceuticals Ltd. (Бангладеш) — доступная альтернатива Olumiant при ревматоидном...

Zepbound (Тирзепатид) 2,5–15мг/0,5мл одноразовая шприц-ручка | Eli Lilly (США) | GLT

Zepbound — одноразовая шприц-ручка тирзепатида Eli Lilly, шесть дозировок для США (2,5–15мг/0,5мл) для хронического контроля...

KeZeRui 科瑞泽 (Аватромбопаг) 20мг*10 таб. | Sichuan Kelun (Китай) | GLT

KeZeRui — аватромбопаг национальной закупки от Sichuan Kelun Pharmaceutical, интегрированного китайского производителя АФС и таблеток.

KangQuXin 康曲欣 (Аватромбопаг) 20 мг × 10 таблеток | Beijing Continent (Gyre) | GLT

KangQuXin — аватромбопаг от Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), Китай

Rizonib (Кризотиниб) 250 мг капсулы | Дженерик Xalkori из Бангладеш (DIL) для ALK+ НМРЛ | GLT

Rizonib 250 от Drug International Ltd (DIL), Тонги Газипур — доступный дженерик кризотиниба из Бангладеш

Barinat (Барицитиниб) 4мг | Дженерик-ингибитор JAK1/JAK2 | Natco Pharma Limited | GLT

Дженерик барицитиниба (ингибитора JAK1/JAK2) от Natco Pharma Limited (Индия) — доступная альтернатива Olumiant при ревматоидном...